Correlation Between Fairfax Financial and Willow Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fairfax Financial and Willow Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fairfax Financial and Willow Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fairfax Financial Holdings and Willow Biosciences, you can compare the effects of market volatilities on Fairfax Financial and Willow Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fairfax Financial with a short position of Willow Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fairfax Financial and Willow Biosciences.

Diversification Opportunities for Fairfax Financial and Willow Biosciences

-0.8
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Fairfax and Willow is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Fairfax Financial Holdings and Willow Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Willow Biosciences and Fairfax Financial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fairfax Financial Holdings are associated (or correlated) with Willow Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Willow Biosciences has no effect on the direction of Fairfax Financial i.e., Fairfax Financial and Willow Biosciences go up and down completely randomly.

Pair Corralation between Fairfax Financial and Willow Biosciences

Assuming the 90 days trading horizon Fairfax Financial is expected to generate 5.76 times less return on investment than Willow Biosciences. But when comparing it to its historical volatility, Fairfax Financial Holdings is 29.93 times less risky than Willow Biosciences. It trades about 0.2 of its potential returns per unit of risk. Willow Biosciences is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  7.50  in Willow Biosciences on October 9, 2024 and sell it today you would earn a total of  0.00  from holding Willow Biosciences or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Fairfax Financial Holdings  vs.  Willow Biosciences

 Performance 
       Timeline  
Fairfax Financial 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Fairfax Financial Holdings are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong technical indicators, Fairfax Financial is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Willow Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Willow Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Fairfax Financial and Willow Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fairfax Financial and Willow Biosciences

The main advantage of trading using opposite Fairfax Financial and Willow Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fairfax Financial position performs unexpectedly, Willow Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Willow Biosciences will offset losses from the drop in Willow Biosciences' long position.
The idea behind Fairfax Financial Holdings and Willow Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets